Table 1.
Characteristics of the studied groups.
| MHMO | MUHMO | p-Value * | |
|---|---|---|---|
| BMI (kg/m2) a | 45.61 ± 7.67 | 49.04 ± 7.80 | 0.155 |
| hsCRP (mg/L) b | 12.05 (4.62–15.77) | 13.36 (7.52–17.64) | 0.200 |
| TNF-α (pg/mL) b | 35.45 (30.21–40.35) | 34.22 (24.4–47.08) | 0.615 |
| Chemerin (ng/mL) b | 30.74 (23–43.71) | 52.5 (34.89–92.2) | 0.044 |
| NOx (μmol/L) a | 54.86 ± 7.14 | 71.77 ± 9.03 | <0.001 |
| TOS (μmol H2O2 equiv./L) a | 86.03 ± 31.20 | 92.60 ± 25.44 | 0.605 |
| TAR (mmol trolox equiv./L b | 0.61 (0.6–0.62) | 0.61 (0.49–1.09) | 0.882 |
| Fasting glucose (mg/dL) b | 85 (79.50–89) | 109 (101–123.5) | <0.001 |
| Fasting insulin (μUI/mL) b | 6.22 (2.12–9.59) | 12.85 (8.57–18.92) | 0.001 |
| HOMA-IR b | 1.37 (0.67–1.90) | 3.56 (2.55–5.65) | <0.001 |
| TC (mg/dL) a | 203.3 ± 29.46 | 203.03 ± 52.68 | 0.984 |
| Triglycerides (mg/dL) b | 102.5 (83–125) | 162.5 (119–205) | 0.003 |
| HDL-C (mg/dL) b | 62.4 (53.5–70.3) | 40 (37.1–49.20) | 0.003 |
| LDL-C (mg/dL) a | 124.55 ± 40.6 | 125.04 ± 53.56 | 0.982 |
MHMO: metabolically healthy morbidly obese, MUHMO: metabolically unhealthy morbidly obese, BMI: body mass index, hsCRP: high sensitivity C-reactive protein, TNF-α: tumor necrosis factor alpha, NOx: nitrites/nitrates, TOS: total oxidant status, TAR: total antioxidant response, HOMA-IR: homeostasis model assessment of insulin resistance, TC: total cholesterol, HDL-C: high density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol; a mean ± standard deviation; b median (interquartile range: percentile 25%–percentile 75%); * Student for independent groups or Mann–Whitney’s test.